Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Sulforaphane may help with hair growth by breaking down a hormone that causes hair loss.

GLP-1 receptor agonists may increase the risk of hair loss, especially non-scarring types, due to weight loss-related nutrient deficiencies.

Changing the 6-position on benzopyran molecules affects insulin release, with some compounds showing strong inhibitory effects.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

Gene therapy shows promise for enhancing physical traits but faces ethical, safety, and regulatory challenges.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

New curcumin analogues help fight prostate cancer by breaking down androgen receptors.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

11β-Hydroxylase inhibitors help prevent seizures in mice by boosting natural neurosteroid production.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Selenium shows promise in preventing and controlling prostate cancer.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

SM04554 may increase hair growth as a topical treatment for androgenetic alopecia.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

GLP-1 medications can cause skin and muscle issues, but treatments like ultrasound and PRP can help.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

Dihydrotestosterone (DHT) increases oil production in skin cells by activating mTOR, and mTOR inhibitors can reduce this effect.

A new peptide, FOL-005, may help treat excessive hair growth by reducing a hair growth promoter, FGF7.

Vitamin D3 analogs can stimulate hair growth in mice with alopecia.